These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 32216773)

  • 41. Non-rapid eye movement sleep instability in mild cognitive impairment: a pilot study.
    Maestri M; Carnicelli L; Tognoni G; Di Coscio E; Giorgi FS; Volpi L; Economou NT; Ktonas P; Ferri R; Bonuccelli U; Bonanni E
    Sleep Med; 2015 Sep; 16(9):1139-45. PubMed ID: 26298791
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Development of a Gustatory Function Test for Clinical Application in Korean Subjects.
    Hwang CS; Kim JW; Al Sharhan SS; Kim JW; Cho HJ; Yoon JH; Kim CH
    Yonsei Med J; 2018 Mar; 59(2):325-330. PubMed ID: 29436203
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Factors affecting the appetites of persons with Alzheimer's disease and mild cognitive impairment.
    Suma S; Watanabe Y; Hirano H; Kimura A; Edahiro A; Awata S; Yamashita Y; Matsushita K; Arai H; Sakurai T
    Geriatr Gerontol Int; 2018 Aug; 18(8):1236-1243. PubMed ID: 29808955
    [TBL] [Abstract][Full Text] [Related]  

  • 44. COWAT Performance of Persons with Alzheimer Dementia, Vascular Dementia, and Parkinson Disease Dementia According to Stage of Cognitive Impairment.
    Lim KB; Kim J; Lee HJ; Yoo J; Kim HS; Kim C; Lee H
    PM R; 2019 Jul; 11(7):737-744. PubMed ID: 30746867
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prediction of Alzheimer's Dementia in Patients with Amnestic Mild Cognitive Impairment in Clinical Routine: Incremental Value of Biomarkers of Neurodegeneration and Brain Amyloidosis Added Stepwise to Cognitive Status.
    Lange C; Suppa P; Pietrzyk U; Makowski MR; Spies L; Peters O; Buchert R;
    J Alzheimers Dis; 2018; 61(1):373-388. PubMed ID: 29154285
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Gustatory Dysfunction as an Early Symptom of Semantic Dementia.
    Sakai M; Kazui H; Shigenobu K; Komori K; Ikeda M; Nishikawa T
    Dement Geriatr Cogn Dis Extra; 2017; 7(3):395-405. PubMed ID: 29430242
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Relationships between gustatory function tests.
    Kang MG; Choi JH; Kho HS
    Oral Dis; 2020 May; 26(4):830-837. PubMed ID: 32003087
    [TBL] [Abstract][Full Text] [Related]  

  • 48. 18F-FDG PET diagnostic and prognostic patterns do not overlap in Alzheimer's disease (AD) patients at the mild cognitive impairment (MCI) stage.
    Morbelli S; Bauckneht M; Arnaldi D; Picco A; Pardini M; Brugnolo A; Buschiazzo A; Pagani M; Girtler N; Nieri A; Chincarini A; De Carli F; Sambuceti G; Nobili F
    Eur J Nucl Med Mol Imaging; 2017 Nov; 44(12):2073-2083. PubMed ID: 28785843
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Behavioral syndromes in mild cognitive impairment and Alzheimer's disease.
    Van der Mussele S; Mariën P; Saerens J; Somers N; Goeman J; De Deyn PP; Engelborghs S
    J Alzheimers Dis; 2014; 38(2):319-29. PubMed ID: 23963290
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Memory performance on the story recall test and prediction of cognitive dysfunction progression in mild cognitive impairment and Alzheimer's dementia.
    Park JH; Park H; Sohn SW; Kim S; Park KW
    Geriatr Gerontol Int; 2017 Oct; 17(10):1603-1609. PubMed ID: 27910252
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Validation study of the Alzheimer's Disease Assessment Scale-Cognitive Subscale for people with mild cognitive impairment and Alzheimer's disease in Chinese communities.
    Yang H; Cheng Z; Li Z; Jiang Y; Zhao J; Wu Y; Gu S; Xu H
    Int J Geriatr Psychiatry; 2019 Nov; 34(11):1658-1666. PubMed ID: 31347192
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Odor identification deficit predicts clinical conversion from mild cognitive impairment to dementia due to Alzheimer's disease.
    Conti MZ; Vicini-Chilovi B; Riva M; Zanetti M; Liberini P; Padovani A; Rozzini L
    Arch Clin Neuropsychol; 2013 Aug; 28(5):391-9. PubMed ID: 23669447
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Awareness disorders in Alzheimer's disease and in mild cognitive impairment].
    Jacus JP; Dupont MP; Herades Y; Pelix C; Large H; Baud M
    Encephale; 2014 Apr; 40(2):180-7. PubMed ID: 24630532
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Design and first baseline data of the DZNE multicenter observational study on predementia Alzheimer's disease (DELCODE).
    Jessen F; Spottke A; Boecker H; Brosseron F; Buerger K; Catak C; Fliessbach K; Franke C; Fuentes M; Heneka MT; Janowitz D; Kilimann I; Laske C; Menne F; Nestor P; Peters O; Priller J; Pross V; Ramirez A; Schneider A; Speck O; Spruth EJ; Teipel S; Vukovich R; Westerteicher C; Wiltfang J; Wolfsgruber S; Wagner M; Düzel E
    Alzheimers Res Ther; 2018 Feb; 10(1):15. PubMed ID: 29415768
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Frequency and subgroups of neuropsychiatric symptoms in mild cognitive impairment and different stages of dementia in Alzheimer's disease.
    Siafarikas N; Selbaek G; Fladby T; Šaltytė Benth J; Auning E; Aarsland D
    Int Psychogeriatr; 2018 Jan; 30(1):103-113. PubMed ID: 28927477
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Study protocol for a randomised, double-blind, placebo-controlled 12-week pilot phase II trial of Sailuotong (SLT) for cognitive function in older adults with mild cognitive impairment.
    Steiner GZ; Bensoussan A; Liu J; Hohenberg MI; Chang DH
    Trials; 2018 Sep; 19(1):522. PubMed ID: 30253809
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Is Mild Cognitive Impairment a Precursor of Alzheimer's Disease? Short Review.
    Janoutová J; Šerý O; Hosák L; Janout V
    Cent Eur J Public Health; 2015 Dec; 23(4):365-7. PubMed ID: 26841152
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Estimating Alzheimer's Disease Progression Rates from Normal Cognition Through Mild Cognitive Impairment and Stages of Dementia.
    Davis M; O Connell T; Johnson S; Cline S; Merikle E; Martenyi F; Simpson K
    Curr Alzheimer Res; 2018; 15(8):777-788. PubMed ID: 29357799
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Accuracy and Psychometric Properties of the Brazilian Version of the Montreal Cognitive Assessment as a Brief Screening Tool for Mild Cognitive Impairment and Alzheimer's Disease in the Initial Stages in the Elderly.
    Pinto TCC; Machado L; Costa MLG; Santos MSP; Bulgacov TM; Rolim APP; Silva GA; Rodrigues-Júnior AL; Sougey EB; Ximenes RCC
    Dement Geriatr Cogn Disord; 2019; 47(4-6):366-374. PubMed ID: 31466064
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Characteristics of Mild Cognitive Impairment Using the Thai Version of the Consortium to Establish a Registry for Alzheimer's Disease Tests: A Multivariate and Machine Learning Study.
    Tunvirachaisakul C; Supasitthumrong T; Tangwongchai S; Hemrunroj S; Chuchuen P; Tawankanjanachot I; Likitchareon Y; Phanthumchinda K; Sriswasdi S; Maes M
    Dement Geriatr Cogn Disord; 2018; 45(1-2):38-48. PubMed ID: 29617684
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.